Saladax Biomedical Inc - Product Pipeline Analysis, 2019 Update

Published by Global Data on 12th November 2019 | Ref: 1463917 | This Product Is In Stock

$750 | Single User
$1500 | Site License
$2250 | Global License
$750 | Single User
$1500 | Site License
$2250 | Global License

Introduction

Summary

Saladax Biomedical Inc (Saladax) is a medical equipment company that develops diagnostic tests. The company provides products such as My5-FU, MyPaclitaxel, MyImatinib and MyDocetaxel, among others. Its My5-FU measures and helps physicians to optimize a patient’s exposure to 5-fluorouracil, MyPaclitaxel is blood test used to measure exposure of patient to paclitaxel, and MyDocetaxel measures patient’s exposure to docetaxel. Saladax’s MyImatinib measures and helps physicians to optimize a patient's exposure to imatinib. The company’s products are used in the treatment of cell lung cancer, digestive tract, prostate, and head and neck cancers. It markets its products in the US and abroad. Saladax is headquartered in Bethlehem, Pennsylvania, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Saladax Biomedical Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Saladax Biomedical Inc Company Overview

Saladax Biomedical Inc Company Snapshot

Saladax Biomedical Inc Pipeline Products and Ongoing Clinical Trials Overview

Saladax Biomedical Inc – Pipeline Analysis Overview

Saladax Biomedical Inc - Key Facts

Saladax Biomedical Inc - Major Products and Services

Saladax Biomedical Inc Pipeline Products by Development Stage

Saladax Biomedical Inc Pipeline Products Overview

MyCare - Clozapine Test

MyCare - Clozapine Test Product Overview

MyCare Assay - Busulfan

MyCare Assay - Busulfan Product Overview

MyCare Assay - Cyclophosphamide

MyCare Assay - Cyclophosphamide Product Overview

MyCare Assay - Doxorubicin

MyCare Assay - Doxorubicin Product Overview

MyCare Assay - Gemcitabine

MyCare Assay - Gemcitabine Product Overview

MyCare Assay - Irinotecan

MyCare Assay - Irinotecan Product Overview

MyCare Assay - Lenalidomide

MyCare Assay - Lenalidomide Product Overview

MyCare Assay - Olanzapine

MyCare Assay - Olanzapine Product Overview

MyCare Assay - Quetiapine

MyCare Assay - Quetiapine Product Overview

MyCare Assay - Thalidomide

MyCare Assay - Thalidomide Product Overview

MyCare Assay - Total Aripiprazole

MyCare Assay - Total Aripiprazole Product Overview

MyCare Assay - Tyrosine Kinase Inhibitor

MyCare Assay - Tyrosine Kinase Inhibitor Product Overview

MyCare Assay - Vincristine

MyCare Assay - Vincristine Product Overview

MyCare Paliperidone Assay Kit

MyCare Paliperidone Assay Kit Product Overview

MyCare Psychiatry Total Risperidone Assay Kit

MyCare Psychiatry Total Risperidone Assay Kit Product Overview

Saladax Biomedical Inc - Key Competitors

Saladax Biomedical Inc - Key Employees

Saladax Biomedical Inc - Locations And Subsidiaries

Head Office

Recent Developments

Saladax Biomedical Inc, Recent Developments

Jul 25, 2018: Saladax Biomedical launches game-changing assays for psychotherapeutics at AACC 2018

Jul 17, 2018: Saladax Submits for FDA Review a Rapid Blood Test for Levels of Risperidone

Mar 21, 2018: Saladax Receives Approval to Sell a New Line of Psychiatry Tests on the European Market

Dec 01, 2014: Saladax Biomedical Announces U.S. Launch of MyImatinib Chemotherapy Exposure Optimization Test

Jul 23, 2014: Fosun Diagnostics receives CFDA Clearance for the MyCare Portfolio of Chemotherapy Exposure Optimization Tests

Jul 23, 2014: Personalized Chemotherapy Tests Cleared for Use in China

Mar 31, 2014: A Dose of Reality About Chemotherapy Dosing - Saladax Has The Antidote - My5-FU

Oct 15, 2013: Saladax Biomedical Laboratories Receives Florida State Laboratory License

Jul 22, 2013: Saladax Biomedical Announces Addition to Leadership Team

Jun 19, 2013: Saladax Biomedical Announces US Launch Of MyCare Portfolio Of Chemotherapy Exposure Optimization Tests

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer

Additional Details

Publisher

Global Data

Publisher Information

Reference

1463917 | GDME2294PD

Number of Pages

38

Report Format

PDF

This report is published by Global Data

Global Data deliver comprehensive, detailed market intelligence that provides a definitive picture of the markets they serve. Their data is complete, detailed, global and completely cross-country comparable.

With different types of data other providers don’t provide, our clients can access a variety of tools that add context to our core data including innovation tracking, sentiment analysis, price monitoring, M&A tracking, competitor intelligence, and city-level intelligence.

Download Free Report Summary PDF

Saladax Biomedical Inc - Product Pipeline Analysis, 2019 Update | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.